Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor)

被引：0
作者：
Luisa Klotz
Berit Grützke
Maria Eveslage
Michael Deppe
Catharina C. Gross
Lucienne Kirstein
Anita Posevitz-Fejfar
Tilman Schneider-Hohendorf
Nicholas Schwab
Sven G. Meuth
Heinz Wiendl
机构：
[1] University Hospital Münster,Department of neurology
[2] Westfaelische Wilhelms-University Münster,Institute of biostatistics and clinical research
来源：
BMC Neurology | / 15卷
关键词：
Multiple sclerosis; Natalizumab; Fingolimod; PML; Switching;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[21]   Fingolimod for Relapsing-Remitting Multiple Sclerosis: The Experience From Saudi Arabia [J].
Algahtani, Hussein ;
Shirah, Bader ;
Al Malik, Yaser ;
Meftah, Ibraheem .
CLINICAL NEUROPHARMACOLOGY, 2020, 43 (02) :35-38
[22]   Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies [J].
Baroncini, Damiano ;
Ghezzi, Angelo ;
Annovazzi, Pietro O. ;
Colombo, Bruno ;
Martinelli, Vittorio ;
Minonzio, Giorgio ;
Moiola, Lucia ;
Rodegher, Mariaemma ;
Zaffaroni, Mauro ;
Comi, Giancarlo .
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (10) :1315-1326
[23]   Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis [J].
Roos, Izanne ;
Sharmin, Sifat ;
Malpas, Charles ;
Ozakbas, Serkan ;
Lechner-Scott, Jeannette ;
Hodgkinson, Suzanne ;
Alroughani, Raed ;
Eichau Madueno, Sara ;
Boz, Cavit ;
van der Walt, Anneke ;
Butzkueven, Helmut ;
Buzzard, Katherine ;
Skibina, Olga ;
Foschi, Matteo ;
Grand'Maison, Francois ;
John, Nevin ;
Grammond, Pierre ;
Terzi, Murat ;
Prevost, Julie ;
Barnett, Michael ;
Laureys, Guy ;
Van Hijfte, Liesbeth ;
Luis Sanchez-Menoyo, Jose ;
Blanco, Yolanda ;
Oh, Jiwon ;
Mccombe, Pamela ;
Ramo Tello, Cristina ;
Soysal, Aysun ;
Prat, Alexandre ;
Duquette, Pierre ;
Yamout, Bassem, I ;
Khoury, Samia ;
van Pesch, Vincent ;
Macdonell, Richard ;
Jose Sa, Maria ;
Slee, Mark ;
Kuhle, Jens ;
Maimone, Davide ;
Spitaleri, Daniele L. A. ;
Willekens, Barbara ;
Asmi, Abdallah Al ;
Tallantyre, Emma ;
Robertson, Neil P. ;
Coles, Alasdair ;
Brown, J. William ;
Kalincik, Tomas .
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (09) :1163-1175
[24]   The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study [J].
Curti, Erica ;
Tsantes, Elena ;
Baldi, Eleonora ;
Caniatti, Luisa Maria ;
Ferraro, Diana ;
Sola, Patrizia ;
Granella, Franco .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 :146-152
[25]   Switching from fingolimod to alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis:. case series [J].
Notas, Konstantinos ;
Papadaki, Efrosini ;
Orologas, Anastasios ;
Moschou, Maria ;
Kimiskidis, Vasilios K. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 38
[26]   Severe disease reactivation in four patients with relapsing-remitting multiple sclerosis after fingolimod cessation [J].
Berger, Benjamin ;
Baumgartner, Annette ;
Rauer, Sebastian ;
Mader, Irina ;
Luetzen, Niklas ;
Farenkopf, Ulrich ;
Stich, Oliver .
JOURNAL OF NEUROIMMUNOLOGY, 2015, 282 :118-122
[27]   Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis [J].
Crespo, C. ;
Izquierdo, G. ;
Garcia-Ruiz, A. ;
Granell, M. ;
Brosa, M. .
NEUROLOGIA, 2014, 29 (04) :210-217
[28]   Natalizumab restores evoked potential abnormalities in patients with relapsing-remitting multiple sclerosis [J].
Meuth, Sven G. ;
Bittner, Stefan ;
Seiler, Carola ;
Goebel, Kerstin ;
Wiendl, Heinz .
MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (02) :198-203
[29]   Cardiac repolarization during fingolimod treatment in patients with relapsing-remitting multiple sclerosis [J].
Laiho, Aapo ;
Laitinen, Tiina M. ;
Hartikainen, Paivi ;
Hartikainen, Juha E. K. ;
Laitinen, Tomi P. ;
Simula, Sakari .
BRAIN AND BEHAVIOR, 2018, 8 (02)
[30]   Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients [J].
Jamroz-Wisniewska, Anna ;
Zajdel, Radoslaw ;
Slowik, Agnieszka ;
Marona, Monika ;
Wnuk, Marcin ;
Adamczyk-Sowa, Monika ;
Adamczyk, Bozena ;
Lasek-Bal, Anetta ;
Puz, Przemyslaw ;
Steposz, Arkadiusz ;
Krzystanek, Ewa ;
Patalong-Ogiewa, Maja ;
Pokryszko-Dragan, Anna ;
Budrewicz, Slawomir ;
Koziarska, Dorota ;
Karbicka, Anna ;
Wawrzyniak, Slawomir ;
Fryze, Waldemar ;
Furtak-Niczyporuk, Marzena ;
Rejdak, Konrad .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
12345